These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Current trials using bone-targeting agents in prostate cancer. Tu SM; Lin SH Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481 [TBL] [Abstract][Full Text] [Related]
7. Palliative treatment of bone metastases in hormone-refractory prostate cancer: effects of pamidronate on the carboxyterminal telopeptide of type-I collagen level in patients with increasing prostate-specific antigen levels. Kawashima H; Tanaka T; Kuratsukuri K; Uchida J; Sugimura K; Tamada S; Nishisaka N; Kumata K; Iwai Y; Ikemoto S; Ezaki K; Nakatani T Urol Int; 2007; 78(4):345-50. PubMed ID: 17495494 [TBL] [Abstract][Full Text] [Related]
8. Management of the spectrum of hormone refractory prostate cancer. Clarke NW Eur Urol; 2006 Sep; 50(3):428-38; discussion 438-9. PubMed ID: 16797118 [TBL] [Abstract][Full Text] [Related]
9. [Molecular-targeted therapy for hormone-refractory prostate cancer]. Nishimura K; Takayama H; Nakayama M; Nonomura N; Okuyama A Hinyokika Kiyo; 2006 Jun; 52(6):487-90. PubMed ID: 16848363 [TBL] [Abstract][Full Text] [Related]
10. Ixabepilone (epothilone B analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111. Hussain M; Tangen CM; Lara PN; Vaishampayan UN; Petrylak DP; Colevas AD; Sakr WA; Crawford ED; J Clin Oncol; 2005 Dec; 23(34):8724-9. PubMed ID: 16314632 [TBL] [Abstract][Full Text] [Related]
16. [The effect of bisphosphonates on bone metastasis of hormone-refractory prostate cancer]. Tanaka T; Kawashima H; Kuratsukuri K; Sugimura K; Nakatani T Hinyokika Kiyo; 2006 Jun; 52(6):491-4. PubMed ID: 16848364 [TBL] [Abstract][Full Text] [Related]
17. Clinical trials in metastatic prostate cancer--has there been real progress in the past decade? Bhandari MS; Petrylak DP; Hussain M Eur J Cancer; 2005 Apr; 41(6):941-53. PubMed ID: 15808960 [TBL] [Abstract][Full Text] [Related]
18. Present status and perspectives in the treatment of hormone-refractory prostate cancer. Silvestris N; Leone B; Numico G; Lorusso V; De Lena M Oncology; 2005; 69(4):273-82. PubMed ID: 16282706 [TBL] [Abstract][Full Text] [Related]
19. Promising novel cytotoxic agents and combinations in metastatic prostate cancer. Bradley DA; Hussain M Cancer J; 2008; 14(1):15-9. PubMed ID: 18303478 [TBL] [Abstract][Full Text] [Related]
20. Recent progress in management of advanced prostate cancer. Kantoff P Oncology (Williston Park); 2005 Apr; 19(5):631-6. PubMed ID: 15945343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]